BSFA BSF Enterprise Plc
BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
PPluang | ||
 BSF Enterprise drops 10.56% as Indigo Capital debt conversion triggers dilution BSF Enterprise PLC (LSE:BSFA, OTC:BSFAF) lost ground on Tuesday after a debt conversion sparked equity dilution concerns across its shareholder base. The tissue engineering, lab-grown materials, and bioactive solutions developer fell 10.56% to 1.12p in morning London trade as the market... | ||
 BSF Enterprise inks worldwide ETSYL commercialisation deal for luxury skincare BSF Enterprise PLC (LSE:BSFA, OTC:BSFAF) has signed heads of terms for the worldwide exclusive commercialisation of its proprietary ETSYL® bioactive peptide across the cosmetics, skincare, dermocosmetics and luxury beauty markets. The agreement with Germany-based SCHAKAU Managementberatung... | ||
 BSF shares jump 56% on US joint venture for lab-grown leather Shares in BSF Enterprise PLC (LSE:BSFA, OTC:BSFAF) soared 56.5% to 1.33p on Monday after the tissue engineering company agreed outline terms for a joint venture to sell its lab-grown leather into the American luxury market. The London-listed group has signed non-binding heads of terms with... | ||